Oaktree Provides $150MM Term Loan to Sorrento Therapeutics

Sorrento Therapeutics, a clinical-stage immunotherapy biotech company, closed a debt financing for up to $150 million. The financing was provided by funds and accounts managed by Oaktree Capital Management.

Hercules Provides $75MM Sorrento Therapeutics Facility

Sorrento Therapeutics, a clinical-stage biopharmaceutical company developing treatments for cancer and other diseases, entered into a loan and security agreement with Hercules Capital for up to $75 million.

Oxford/SVB Expand Term Loan with Sorrento Therapeutics

Oxford Finance and Silicon Valley Bank announced a $7.5 million expansion to an existing $5 million term loan with Sorrento Therapeutics.